 | |
L.B. Bohle Maschinen + Verfahren GmbH from Ennigerloh, Germany has started a cooperative with the research and development company, Formula – Pharmazeutische und Chemische Entwicklungsgesellschaft mbH from Berlin, Germany.
The basis of this cooperation was the newly founded L.B. Bohle Formula. Pharma Services GmbH at the end of 2007.
In April 2008, L.B. Bohle Maschinen + Verfahren GmbH received authorization to produce (§13 AMG) clinical batches in bulk and market products in pilot/production scale (5 – 20 kgs). The new company merges the core competencies of plant engineering with research and development expertise into a qualified partner for pharmaceutical companies. The L.B. Bohle Service Center provides well-known, state of the art production equipment. In addition to feasibility studies and clinical supplies, pharmaceutical products for marketing purposes are being manufactured under GMP conditions.
Dr. Christian Brätter, CEO of L.B. Bohle Formula. Pharma Services GmbH, states “The new company offers a large variety of services. On one hand the customer can benefit from the long time L.B. Bohle know how in engineering. On the other hand, the client can benefit from our experience in research, development and clinical batch production as well as formulation release from the authorities. So you will get full service and expert consultation from a single source.” Further information and a performances overview are available at our homepage
|
